We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $8.48B
1-Year Est. Return 99.04%
This Fund
S&P 500
This Quarter Est. Return
+21.5%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$5.75B
AUM Growth
+$332M
Cap. Flow
-$28.9M
Cap. Flow %
-0.5%
Top 10 Hldgs %
51.71%
Holding
444
New
223
Increased
65
Reduced
45
Closed
77

Top Buys

Rank Stock Value
1
BNTX icon
BioNTech
BNTX
+$54.6M
2
KYTX icon
Kyverna Therapeutics
KYTX
+$40.8M
3
SGRY icon
Surgery Partners
SGRY
+$33.8M
4
LRMR icon
Larimar Therapeutics
LRMR
+$33.4M
5
ALHC icon
Alignment Healthcare
ALHC
+$30.6M

Top Sells

Rank Stock Value
1
RYZB
RayzeBio, Inc. Common Stock
RYZB
+$62.6M
2
SWTX
SpringWorks Therapeutics
SWTX
+$60.2M
3
BAX icon
Baxter International
BAX
+$55M
4
VKTX icon
Viking Therapeutics
VKTX
+$36.3M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$28.1M

Sector Composition

Rank Sector Weight
1 Healthcare 88.87%
2 Industrials 0.71%
3 Technology 0.31%
4 Consumer Discretionary 0.26%
5 Financials 0.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WBD icon
176
Warner Bros
WBD
$64.2B
$413K 0.01%
47,346
+28,145
+147% +$271K
NTRS icon
177
Northern Trust
NTRS
$22.2B
$407K 0.01%
4,582
+1,482
+48% +$122K
BA icon
178
Boeing
BA
$175B
$407K 0.01%
+2,109
New +$433K
FIVE icon
179
Five Below
FIVE
$11.5B
$405K 0.01%
+2,232
New +$430K
CYTK icon
180
Cytokinetics
CYTK
$10.8B
$404K 0.01%
5,764
+2,600
+82% +$201K
GM icon
181
General Motors
GM
$81.7B
$398K 0.01%
8,774
+1,698
+24% +$65.8K
BCSF icon
182
Bain Capital Specialty
BCSF
$833M
$398K 0.01%
+25,356
New +$392K
ESAB icon
183
ESAB
ESAB
$5.54B
$392K 0.01%
+3,546
New +$331K
GL icon
184
Globe Life
GL
$13.9B
$391K 0.01%
+3,363
New +$412K
GPRO icon
185
GoPro
GPRO
$125M
$391K 0.01%
175,149
+141,036
+413% +$377K
HURN icon
186
Huron Consulting
HURN
$1.97B
$388K 0.01%
4,015
+950
+31% +$96.3K
BHF icon
187
Brighthouse Financial
BHF
$3.66B
$388K 0.01%
+7,520
New +$373K
MATW icon
188
Matthews International
MATW
$900M
$387K 0.01%
+12,438
New +$385K
HCI icon
189
HCI Group
HCI
$2.29B
$387K 0.01%
3,330
-740
-18% -$72.7K
DD icon
190
DuPont de Nemours
DD
$19B
$385K 0.01%
+4,000
New +$356K
HXL icon
191
Hexcel
HXL
$8.3B
$383K 0.01%
5,259
+1,027
+24% +$73.9K
HQY icon
192
HealthEquity
HQY
$8.46B
$380K 0.01%
+4,660
New +$364K
INCY icon
193
Incyte
INCY
$26B
$380K 0.01%
6,672
+2,007
+43% +$120K
BFAM icon
194
Bright Horizons
BFAM
$4.24B
$378K 0.01%
+3,332
New +$351K
KELYA icon
195
Kelly Services Class A
KELYA
$560M
$377K 0.01%
+15,063
New +$338K
BRBR icon
196
BellRing Brands
BRBR
$1.59B
$374K 0.01%
+6,344
New +$361K
J icon
197
Jacobs Solutions
J
$16.6B
$372K 0.01%
+2,928
New +$343K
IVT icon
198
InvenTrust Properties
IVT
$2.81B
$372K 0.01%
+14,470
New +$364K
ORCL icon
199
Oracle
ORCL
$346B
$371K 0.01%
+2,950
New +$338K
DLX icon
200
Deluxe
DLX
$1.25B
$368K 0.01%
+17,885
New +$356K
6 7
8
9 10

Similar funds

FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Deerfield Management's Q1 2024 Portfolio in Review

As of Q1 2024, Deerfield Management held 444 positions worth $5.75B, up 6.1% from $5.42B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Deerfield Management's Q1 2024 filing shows 223 new, 65 increased, 45 reduced and 77 closed positions. Its largest new stake was BioNTech: 569,574 shares worth $52.5M. The largest sale was RayzeBio, Inc. Common Stock, an estimated $62.6M.

By sector, the portfolio is most concentrated in Healthcare at 89% of assets, up from 78% a quarter earlier, followed by Industrials and Technology.

  • Deerfield Management's largest Q1 2024 buy was BioNTech: 569,574 shares worth $52.5M.
  • Deerfield Management added most to Surgery Partners in Q1 2024, an estimated $33.8M increase.
  • Deerfield Management's biggest Q1 2024 reduction was SpringWorks Therapeutics, cutting an estimated $60.2M.
  • Deerfield Management fully exited RayzeBio, Inc. Common Stock in Q1 2024, selling an estimated $62.6M.
  • Deerfield Management's ten largest holdings make up 52% of its $5.75B portfolio in Q1 2024.
  • Deerfield Management opened 223 new positions and closed 77 in Q1 2024.
  • Deerfield Management's portfolio value rose 6.1% quarter-over-quarter to $5.75B.

Based on Deerfield Management's 13F filing for Q1 2024, filed 15 May 2024.